Study of BNIP3L Gene in Breast and Ovarian Cancer
Author Information
Author(s): Lai J, Flanagan J, Phillips W A, Chenevix-Trench G, Arnold J
Primary Institution: The Queensland Institute of Medical Research
Hypothesis
Does the BNIP3L gene function as a tumor suppressor in breast and ovarian cancer?
Conclusion
The study suggests that BNIP3L is not the target of 8p LOH in ovarian and breast tumors despite its location in regions associated with loss of heterozygosity.
Supporting Evidence
- BNIP3L is located at 8p21, a region associated with tumor suppressor genes.
- LOH was observed in 41% of ovarian tumors and 28% of breast tumors.
- Expression of BNIP3L was detected in all breast and ovarian cancer cell lines studied.
Takeaway
Researchers looked at a gene called BNIP3L to see if it helps stop breast and ovarian cancer, but they found it doesn't seem to play a big role.
Methodology
The study analyzed BNIP3L expression in various breast and ovarian cancer cell lines and primary tumors, screening for mutations and loss of heterozygosity.
Limitations
The study did not find significant downregulation of BNIP3L expression in cancer cell lines, suggesting other genes may be involved in tumor suppression.
Participant Demographics
The study included 40 patients with ovarian tumors and 25 patients with breast tumors.
Statistical Information
P-Value
0.03
Statistical Significance
p=0.03
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website